A Beginner’s Guide to the Lungs
July 11, 2026
A Beginner’s Guide to the Lungs 1. Overview and Key Facts The lungs act as the body’s gas exchange system. They process thousands of litres of air every day to deliver vital oxygen to the ...
As of March 2026, COVID-19 activity in the UK has reached a “baseline level” of circulation. While the virus is no longer in a pandemic phase, the UK Health Security Agency (UKHSA) and WHO continue to monitor seasonal surges and the dominant Stratus (XFG) variant.
Data from the peak of the 2025 autumn/winter season shows that while cases fluctuated, medical interventions have stabilized mortality rates.
UK Statistical Snapshot (Peak Season 2025)
| Metric | Value | Status |
| Weekly Cases (UK) | ~2,000 | 📈 Rising (Sept 2025 peak) |
| Weekly Deaths (UK) | ~100 | ⚖️ Stable (0.5% Mortality) |
| Vaccine Uptake | 60% | ✅ Target Achieved (Eligible Groups) |
| Global Cases (Monthly) | 115,000 | 🌍 WHO Global Monitoring |
The dominant strain in 2026 is the Stratus variant (XFG). This is a “recombinant” variant, meaning it formed from two previous Omicron sub-variants.
Transmissibility: Higher than previous strains due to enhanced immune escape.
Severity: Clinical data suggests no increase in severe disease compared to 2024–2025 variants.
Key Symptom: In 2026, a severe sore throat is the most frequently reported primary symptom.
The UKHSA now monitors COVID-19 alongside other major respiratory threats. In the current 2025/26 season, COVID-19 has transitioned into a predictable pattern compared to other viruses:
Rhinovirus (Common Cold): Remains the most prevalent cause of mild respiratory illness.
Influenza (Flu): Primarily the A(H3N2) strain this season; circulating at baseline levels.
RSV (Respiratory Syncytial Virus): Decreasing in early 2026 after a typical winter peak in children and the elderly.
COVID-19: Stable; hospital admissions remain low at approximately 0.80 per 100,000 people.
The Spring 2026 Booster Program is currently underway. Eligibility is strictly targeted to protect those at highest risk of hospitalisation.
Eligible Groups: Adults aged 75+, residents in care homes for older adults, and individuals aged 6 months+ with weakened immune systems.
Efficacy: The updated 2025/26 vaccines are highly effective against the Stratus (XFG) variant, significantly reducing the risk of “Long COVID.”
Top Tip: If you are eligible, the NHS recommends co-administration (having your Flu and COVID-19 jabs at the same time) for maximum winter protection.
For detailed clinical advice and the latest health updates, explore our expert-led guides:
Stratus Variant: Why COVID-19 Cases are Rising Again: Deep dive into the genetics and spread of the XFG variant.
10 Essential COVID-19 Facts: Essential knowledge for navigating the post-pandemic era.
COVID-19 Red Flags: Learn the serious symptoms that require urgent medical attention.
How to Test for COVID-19: Updated guidance on testing and what a positive LFT looks like.
A Beginner’s Guide to the Lungs 1. Overview and Key Facts The lungs act as the body’s gas exchange system. They process thousands of litres of air every day to deliver vital oxygen to the ...
What are the 10 Most Common Tablets for Chronic Heart Failure? Managing Chronic Heart Failure (CHF)—also known as Congestive Cardiac Failure (CCF)—is a complex task. The goal of modern med...
COVID-19 Information & Resource Hub (2026 Update) Since the emergence of SARS-CoV-2 in late 2019, COVID-19 has transitioned from a global pandemic to a managed seasonal respiratory infection. As o...
COVID-19 and High Cholesterol: Why you Should Check your Lipids After COVID 1. The COVID-Cholesterol Connection Beyond respiratory issues, 2026 data identifies COVID-19 as a major metabolic disruptor....
